# K093203: Cardioblate Bipolar Radiofrequency Surgical Ablation System, Models 60831, 60832, 60841

- Pathway: 510(k) (Special)
- Applicant: Medtronic, Inc.
- Decided: Feb 26, 2010 after 136 days
- Product code: GEI (Electrosurgical, Cutting & Coagulation & Accessories)
- Device class: 2
- Regulation: 21 CFR 878.4400
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 10 generations back to K942299 (1995). 55 ancestors in all.
3 later devices descend from it; 1 cites it directly.
0 of 59 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K080509: Cardioblate 68000 Gnerator, BP2 Surgical Ablation Device, LP Surgical Ablation Device, Gemini-Ssurgical Ablation Device, Medtronic, Inc. (2008) Summary page 1.

## Most influential descendants
- K182610: Valleylab FT10 Electrosurgical Platform, Cardioblate BP2 Surgical Ablation Device, Cardioblate LP Surgical Ablation Device (2018), 2 descendants of its own
- K191601: Valleylab FT10 Electrosurgical Platform (2019), 1 descendant of its own
- K241085: Valleylab ™FT10 Energy Platform Software Version 5.0 (VLFT10GEN VLFT10FXGEN VLFT10LSGEN) (2024), 0 descendants of its own

## Indications for use
The Medtronic Cardioblate® System is intended to ablate cardiac tissue during cardiac surgery using radiofirequency energy.

Source page: https://510kreport.com/device/K093203
Methodology: https://510kreport.com/methodology